Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Start-up VentiRx completes $26.6mm Series A; adds $25mm

Executive Summary

VentiRx Pharmaceuticals, which is concentrating on oncologic, anti-infective, respiratory, and immunological medicines, raised $26.6mm in its Series A financing led by Frazier Healthcare Ventures, Arch Venture Partners, and Domain Associates. A representative from Domain joins the company's board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies